MAX - SHOCK Clinical Trial
Recruiting · NCT06556667 · Interventional (participants receive a specific treatment) · Lead sponsor: Ottawa Heart Institute Research Corporation
View the official record on ClinicalTrials.gov →Interventions studied
biphasic defibrillator with maximum energy of 200J (® Zoll)biphasic defibrillator with maximum energy of 360J (® Physio-Control)
What this trial is about
Can Electrical Cardioversion (ECV) for AF be improved. It is the preferred method to restore sinus rhythm in patients with AF in whom a rhythm-control strategy is pursued. Hypothesis: ECV success rates will be greater with a biphasic defibrillator with maximum energy of 360J (® Physio-Control) compared to a biphasic defibrillator with maximum energy of 200J (® Zoll)
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Patients age \> 18 years.
- Persistent atrial fibrillation.
- Scheduled for elective cardioversion at UOHI
- Patient is within the circle of care of UOHI Electrophysiology staff
Exclusion criteria
- Known left-atrial appendage thrombus.
- Contraindication to appropriate anticoagulation.
- Patient is included in another randomized clinical trial.
- Patient does not meet all of the above listed inclusion criteria.
Where it is running
1 location listed.
- University of Ottawa Heart Institute - Ottawa, Ontario, Canada